Longitudinal Analysis Of Mitochondrial D-Loop Methylation And Copy Number In Peripheral Blood: Epigenetic Signatures Of Alzheimer’S Disease Progression And Aging
Our cells contain tiny powerhouses called mitochondria, which have their own DNA, separate from the main DNA in the cell nucleus. This mitochondrial DNA (mtDNA) plays a crucial role in energy production. Recent research suggests that problems with these mitochondria are linked to conditions like Alzheimer’s disease.
Scientists have been investigating how changes in mtDNA might signal the progression of such diseases. One key area of focus is “methylation,” a natural process where chemical tags attach to DNA, influencing how genes are expressed without changing the underlying genetic code. Another important factor is the “mtDNA copy number,” which refers to how many copies of mitochondrial DNA are present in a cell.
In a recent study, researchers tracked these specific changes in blood samples from individuals over eight years. They observed that healthy individuals showed a gradual increase in methylation on a particular region of their mtDNA, known as the D-loop. However, individuals who were progressing towards Alzheimer’s disease exhibited the opposite trend: a noticeable decrease in this D-loop methylation and an increase in their mtDNA copy number.
These findings suggest that a reduction in D-loop methylation and a rise in mtDNA copy number could be indicators of mitochondrial dysfunction and the advancement of Alzheimer’s. Conversely, increased methylation might represent a protective mechanism against the disease. Understanding these molecular shifts could pave the way for earlier detection and better monitoring of Alzheimer’s disease progression.
Source: link to paper